ATE332709T1 - Stabilisiertes arzneimittel enthaltend cysteinylderivate - Google Patents

Stabilisiertes arzneimittel enthaltend cysteinylderivate

Info

Publication number
ATE332709T1
ATE332709T1 AT97919382T AT97919382T ATE332709T1 AT E332709 T1 ATE332709 T1 AT E332709T1 AT 97919382 T AT97919382 T AT 97919382T AT 97919382 T AT97919382 T AT 97919382T AT E332709 T1 ATE332709 T1 AT E332709T1
Authority
AT
Austria
Prior art keywords
product containing
medicinal product
stabilized medicinal
derivatives
containing cysteinyl
Prior art date
Application number
AT97919382T
Other languages
English (en)
Inventor
Fritz Stanislaus
Original Assignee
Fritz Stanislaus
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fritz Stanislaus filed Critical Fritz Stanislaus
Priority claimed from EP97919382A external-priority patent/EP0971743B1/de
Application granted granted Critical
Publication of ATE332709T1 publication Critical patent/ATE332709T1/de

Links

AT97919382T 1997-04-18 1997-04-18 Stabilisiertes arzneimittel enthaltend cysteinylderivate ATE332709T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP97919382A EP0971743B1 (de) 1997-04-18 1997-04-18 Stabilisiertes arzneimittel enthaltend cysteinylderivate

Publications (1)

Publication Number Publication Date
ATE332709T1 true ATE332709T1 (de) 2006-08-15

Family

ID=36782333

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97919382T ATE332709T1 (de) 1997-04-18 1997-04-18 Stabilisiertes arzneimittel enthaltend cysteinylderivate

Country Status (1)

Country Link
AT (1) ATE332709T1 (de)

Similar Documents

Publication Publication Date Title
DE59712694D1 (de) Stabilisiertes arzneimittel enthaltend cysteinylderivate
ATE248594T1 (de) Irbesartanhaltiges arzneimittel
ATE240732T1 (de) Ziprasidonhaltige arzneimittel
ATE202472T1 (de) Arzneimittel enthaltend oxaliplatin
DE69513671D1 (de) Arzneimittel
DE122010000011I1 (de) Flüssige gonadotropinhaltige Arzneimittel
ATE367150T1 (de) Arzneimittel
ATE219089T1 (de) Triazol-derivate als arzneimittel
PT858325E (pt) Formulacao farmaceutica liofilizada estavel
ATE285774T1 (de) Ranolazinhaltige arzneimittel mit verzögerter wirkstoffabgabe
DE69831620D1 (de) Arzneizubereitungen enthaltend Kannabinoide
DE69615887D1 (de) Oral anzuwendende Arzneizubereitung enthaltend Olanzapin
DE69814091D1 (de) Voriconazol-enthaltende pharmazeutische zubereitungen
NO981008D0 (no) Farmasöytisk formulering
ATE237320T1 (de) Venlafaxinhaltiges arzneimittel mit verlängerter wirkstoffabgabe
EP0823255A4 (de) Sucralfat enthaltendes arzneimittel
DE69812708T2 (de) Neue arzneimittel enthaltend uridintriphosphat
ATE216238T1 (de) Arzneimittel enthaltend lipidsenkende verbindungen
IL134538A (en) Lactacystin derivatives and pharmaceutical compositions containing the same
DE69709349D1 (de) Arzneimittel bestehend aus diclofenac
IS5062A (is) Lyfjablöndur sem innihalda afleiður N-súlfonýlindólíns
IT1302969B1 (it) Confezione per sostanze medicinali
EE9800275A (et) Misolastiini sisaldavad prolongeeritud toimega farmatseutilised preparaadid
ATE269337T1 (de) Trizyclische delta3-pyridine als arzneimittel
FI973230A0 (fi) Uusi farmaseuttinen formulaatio

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee